Twitxy Saved

Matthew Rees

@MattReesMD

Haematologist | St Vincent’s Hospital Melbourne | Focus: Myeloma & AL amyloidosis & Immunotherapy |Collaborator: Mayo Clinic, ALLG, AAN. Views are my own.
Joined November 2024
82 Following 25 Followers 17 Posts

Latest posts 3

Matthew Rees @MattReesMD
New @AlbertYunes study: EBV+ polymorphic B-cell LPD (NOS) — first real-world cohort outside the transplant setting.
🧍‍♂️31 pts | Strong responses to rituximab ± immunosuppression reduction.
🧠 CNS cases can remit; rebiopsy crucial at relapse.
🔗 nature.com/articles/s4140…
www.nature.com EBV+ polymorphic B-cell lymphoproliferative disorder, NOS: a single-center study of a newly... Blood Cancer Journal - EBV+ polymorphic B-cell lymphoproliferative disorder, NOS: a single-center study of a newly recognized pathologic entity
Matthew Rees @MattReesMD
Proteomic determinants of renal organ response in light-chain amyloidosis tandfonline.com/doi/full/10.10…. The non-amyloid protein constituents of amyloid plaques identified on mass spectrometry may inform a patients’ likelihood of organ recovery. @Taxkourel
www.tandfonline.com Proteomic determinants of renal organ response in light-chain amyloidosis Published in Amyloid: The Journal of Protein Folding Disorders (Vol. 32, No. 2, 2025)